Delving into the Latest Updates on Harbin Pharmaceutical Group Sixth Pharm Factory with Synapse

Overview

Tags

Nervous System Diseases

Other Diseases

Infectious Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Nervous System Diseases	3
Infectious Diseases	2
Endocrinology and Metabolic Disease	1
Immune System Diseases	1

Top 5 Drug Type	Count

Small molecule drug	4

Top 5 Target	Count

COX(Cyclooxygenases)	1
50S subunit(50S ribosomal subunit)	1

The objective of this paper was to prepare self-emulsifying drug delivery systems of genistein.Through drawing pseudo-ternary phase diagrams and evaluating self-emulsification efficiency, the optimum formulation was obtained for genistein.RP-HPLC was used to determine the content of genistein.In the optimum formulation, Et oleate, T₅C₅ (50% Tween 80-50% Cremophor EL35) and 1,2-propanediol were selected as oil phase, emulsifier and cosolvent, resp., with the proportion of 45:45:10.The content of genistein was fixed at 10% (weight/weight) of the vehicle.The SEDDS of genistein was prepared, which was suitable to prepare soft capsules.

Heilongjiang Yiyao

Separation of toxic alkaloids from Aconitum carmichaeli

Author: Tang, Qingxu

A method was established for extracting and separating mesaconitine, aconitine and hypaconitine.The recovery of this method was similar to that of alk. benzene method.This method was at low cost, harmless and suitable for extracting, separating and preparing mesaconitine, aconitine and hypaconitine.

100 Deals associated with Harbin Pharmaceutical Group Sixth Pharm Factory

Login to view more data

100 Translational Medicine associated with Harbin Pharmaceutical Group Sixth Pharm Factory

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

4

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Erythromycin Ethylsuccinate ( 50S subunit )	Bacterial Infections More	Approved
Fenbufen	Inflammation More	Approved
Diclofenac Sodium ( COX )	Pain More	Approved
Lappaconite Hydrobromide	Pain More	Approved